Robert Beardsley
Founder chez GALERA THERAPEUTICS, INC.
Fortune : 15 147 $ au 31/03/2024
Profil
Robert A.
Beardsley is the founder and the Chief Operating Officer of Galera Therapeutics, Inc., which was founded in 2009.
He is also the founder of Simile Investors LLC.
Dr. Beardsley's former job positions include being the President & Chief Executive Officer of Kereos, Inc. from 2003 to 2012, the Chief Executive Officer of Metabolic Solutions Development Co. LLC from 2009 to 2010, the Chairman & Chief Executive Officer of Galera Therapeutics LLC in 2012, and the Chief Executive Officer of Metaphore Pharmaceuticals, Inc. from 2000 to 2006.
He has also held positions as Chairman of Epigenetx LLC, Director of CollaGenex Pharmaceuticals, Inc. from 2004 to 2008, Director of Zevra Therapeutics, Inc., Director of Euclises Pharmaceuticals, Inc., Director of BioSeek, Inc., Director of PharmaMonde, Inc., Chief Business Officer of Aclaris Life Sciences, Inc., Principal of Vector Securities International, Inc., and Principal of Biostrategies Group.
Dr. Beardsley's education includes an MBA from The University of Chicago and a doctorate from the University of Iowa.
Dr. Beardsley is also the founder of Simile Investors LLC.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/02/2023 | 108 191 ( 0,20% ) | 15 147 $ | 31/03/2024 |
Postes actifs de Robert Beardsley
| Sociétés | Poste | Début |
|---|---|---|
| GALERA THERAPEUTICS, INC. | Founder | 01/01/2009 |
Anciens postes connus de Robert Beardsley
| Sociétés | Poste | Fin |
|---|---|---|
Galera Therapeutics LLC
 Galera Therapeutics LLC Medical/Nursing ServicesHealth Services Galera Therapeutics LLC provides and develops drugs. The firm is dedicated to the development of innovative, effective and safe medicines to treat cancer and prevent the side effects associated with current treatment regimens. Galera Therapeutics was founded in 2009 and is headquartered in St. Louis, MO. | Chief Executive Officer | 11/12/2012 |
Metabolic Solutions Development Co. LLC
 Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | Chief Executive Officer | 01/01/2010 |
CollaGenex Pharmaceuticals, Inc.
 CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Director/Board Member | 11/04/2008 |
Metaphore Pharmaceuticals, Inc.
 Metaphore Pharmaceuticals, Inc. BiotechnologyHealth Technology Metaphore Pharmaceuticals, Inc. is a pharmaceutical company which discovers, develops and markets drugs that prevent and treat pain, autoimmune disorders and inflammation. The company leverages its expertise in chemistry and biology to discover and develop small molecule compounds that mimic the activity of human enzymes. The company's compounds mimic the function of superoxide dismutase (SOD), a beneficial enzyme that serves an important protective role in the body by removing superoxide, a toxic free radical that can damage cells and tissues. Superoxide anions are implicated in a variety of diseases associated with pain and inflammation. The company is headquartered in St. Louis, MO. | Chief Executive Officer | 01/06/2006 |
Epigenetx LLC
 Epigenetx LLC BiotechnologyHealth Technology Epigenetx LLC develops drugs and therapies. The company is headquartered in St. Louis, MO. | Chairman | - |
Formation de Robert Beardsley
| The University of Chicago | Masters Business Admin |
| University of Iowa | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| GALERA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 13 |
|---|---|
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Health Technology |
Kereos, Inc.
 Kereos, Inc. Pharmaceuticals: MajorHealth Technology Kereos, Inc. develops and manufactures biotechnology products. The firm focuses on nanodroplet technology that allows delivery of a range of drug compounds to a target in the body for the treatment of diseases. The company was founded by Samuel A. Wickline and Gregory M. Lanza in 1999 and is headquartered in St. Louis, MO. | Health Technology |
Metabolic Solutions Development Co. LLC
Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | Health Technology |
Galera Therapeutics LLC
Galera Therapeutics LLC Medical/Nursing ServicesHealth Services Galera Therapeutics LLC provides and develops drugs. The firm is dedicated to the development of innovative, effective and safe medicines to treat cancer and prevent the side effects associated with current treatment regimens. Galera Therapeutics was founded in 2009 and is headquartered in St. Louis, MO. | Health Services |
Euclises Pharmaceuticals, Inc.
 Euclises Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Euclises Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform and is in the process of selecting a lead clinical development candidate. The company was founded by John J. Talley in 2011 and is headquartered in St. Louis, MO. | Health Services |
Aclaris Life Sciences, Inc.
 Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Health Services |
Epigenetx LLC
Epigenetx LLC BiotechnologyHealth Technology Epigenetx LLC develops drugs and therapies. The company is headquartered in St. Louis, MO. | Health Technology |
Metaphore Pharmaceuticals, Inc.
Metaphore Pharmaceuticals, Inc. BiotechnologyHealth Technology Metaphore Pharmaceuticals, Inc. is a pharmaceutical company which discovers, develops and markets drugs that prevent and treat pain, autoimmune disorders and inflammation. The company leverages its expertise in chemistry and biology to discover and develop small molecule compounds that mimic the activity of human enzymes. The company's compounds mimic the function of superoxide dismutase (SOD), a beneficial enzyme that serves an important protective role in the body by removing superoxide, a toxic free radical that can damage cells and tissues. Superoxide anions are implicated in a variety of diseases associated with pain and inflammation. The company is headquartered in St. Louis, MO. | Health Technology |
BioSeek, Inc.
 BioSeek, Inc. Miscellaneous Commercial ServicesCommercial Services BioSeek, an Asterand company, is improving the success rate of pharmaceutical research and development by integrating human biology from the earliest stages of drug discovery onward. Their BioMAP® Systems incorporate predictive primary human cell-based disease models that generate uniquely informative biological activity profiles for each potential drug. As a result, their technology drives the selection and development of new drug candidates. they leverage their BioMAP® Systems technology in collaborations to enhance the productivity of their pharmaceutical partners' pipelines to identify promising compounds for therapeutic development. Asterand plc acquired BioSeek on February 18, 2010. Asterand is the leading global supplier of high quality, well characterized human tissue and human tissue-based research services to drug discovery scientists. BioSeek's BioMAP® platform and primary human cell based assays are highly complementary to the human tissue-based products and services offered by Asterand. Formed in January 2006 from the merger of Asterand, a human tissue biorepository, and Pharmagene, a human tissue-based drug discovery company, Asterand plc is uniquely positioned to provide a comprehensive approach to meet the research needs of pharmaceutical and biotechnology companies. From their offices in Royston (United Kingdom), San Francisco, California and Detroit, Michigan they have more than 90 employees focused on providing services and products to accelerate drug discovery research from target identification through to compound evaluation and drug safety. | Commercial Services |
| Vector Securities International, Inc. | Finance |
Simile Investors LLC
 Simile Investors LLC Financial ConglomeratesFinance Simile Investors LLC functioned as investment holding company. The company was headquartered in San Diego, CA. | Finance |
Biostrategies Group
 Biostrategies Group Miscellaneous Commercial ServicesCommercial Services Part of CRA International, Inc., Biostrategies Group is a consulting private company. The company is based in Chicago, IL. The company was founded in 1995. Biostrategies Group was acquired by CRA International, Inc. on November 29, 2022. | Commercial Services |
PharmaMonde, Inc.
 PharmaMonde, Inc. Investment ManagersFinance PharmaMonde, Inc. provides business advisory services. The form offers business development, corporate and business law, technology transfers, licensing, mergers and acquisitions, join ventures and financing transaction services. The company was founded by Vincent Taillefer and is headquartered in Longueuil, Canada. | Finance |
